Rahimi-Nedjat, R. K.; Sagheb, K.; Tuettenberg, A. et al.
How is Your Diagnosis? Localized, irregular Pigmentation of the Maxillary GingivaHAUTARZT. Bd. 67. H. 4. 2016 S. 326-329
Fridrich, Sven; Hahn, Susanne A.; Linzmaier, Marion et al.
How Soluble GARP Enhances TGF beta ActivationPLOS ONE. Bd. 11. H. 4. 2016
Tomcin, Stephanie; Kelsch, Annette; Staff, Roland H. et al.
HPMA-based block copolymers promote differential drug delivery kinetics for hydrophobic and amphiphilic moleculesACTA BIOMATERIALIA. Bd. 35. 2016 S. 12-22
Domogalla, M. P.; Frick, S. U.; Baier, G. et al.
Hydroxyethyl starch nanocapsules as a potent drug-delivery system for targeting of CD4+CD25+T cells with different IL-2 receptor affinitiesEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E24-E24
Raker, V. K.; Kryczanowsky, F.; Graulich, E. et al.
Identification of a stable and migratory subset of tolerogenic IL-10 modulated human dendritic cells for optimized DC vaccination strategiesEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E19-E19
Kryczanowsky, Fanny; Raker, Verena; Graulich, Edith et al.
IL-10-Modulated Human Dendritic Cells for Clinical Use: Identification of a Stable and Migratory Subset with Improved Tolerogenic ActivityJOURNAL OF IMMUNOLOGY. Bd. 197. H. 9. 2016 S. 3607-3617
Heppt, M.; Eigentler, T.; Kahler, K. et al.
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysisJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. 2016 S. 10-10
Heppt, Markus V.; Eigentler, Thomas K.; Kaehler, Katharina C. et al.
Immune checkpoint blockade with concurrent electrochemotherapy in advanced melanoma: a retrospective multicenter analysisCANCER IMMUNOLOGY IMMUNOTHERAPY. Bd. 65. H. 8. 2016 S. 951-959
Wilden, Sophia M.; Lang, Berenice M.; Mohr, Peter et al.
Immune checkpoint inhibitors: a milestone in the treatment of melanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 14. H. 7. 2016 S. 685-695
Schermann, A. I.; Lorenz, B.; Tenzer, S. et al.
Immunization with a newly identified Leishmania (L.) major-specific protein (80 kDa) promotes protection in mice against infection with L. major parasitesEXPERIMENTAL DERMATOLOGY. Bd. 25. H. 3. 2016 S. E30-E30